Check-Cap Ltd. released its annual report for the fiscal year ending December 31, 2024. The company reported that it has not generated any revenue since its inception. To date, operations have been funded primarily through equity financings and grants from the Israel Innovation Authority (IIA). Operating costs and expenses are categorized into research and development expenses and general and administrative expenses, with personnel costs being the largest component in both categories. The company has outlined its ongoing and planned product development efforts, which, if successful, are expected to eventually generate revenue from sales of their C-Scan product. As part of its strategic plans, Check-Cap is evaluating and pursuing options, including a Business Combination Agreement with Nobul. The company continues to focus on obtaining regulatory approvals for its product candidates and developing commercial functions to support a potential product launch. Check-Cap remains focused on its cash needs, financial condition, liquidity, and growth strategies as it navigates the trends affecting its industry.